MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
New initiative aims to drive forward clinical trial research for MDR TB
At the annual TB Union Conference held in Cape Town in November 2007, a number of actors, concerned by the continuing lack of sufficient research activity to tackle drug-resistant TB, decided to launch a new initiative.
The first fruit was a workshop held in Boston, USA in June 2008 on drug resistant TB that brought together representatives from National Treatment Programmes from countries with high burden MDR TB, NGOs, activist groups, scientists and researchers, pharmaceutical industry and representatives from regulating agencies and funders.
The participants decided to set up a new entity, focusing initially on the development of a proposal to move forward in the conduct of MDR TB clinical trials. The group also issued a manifesto, The Cambridge Declaration, outlining their aims.
These include the conduct of the most important priority trials to test strategies that will shorten and improve treatment for drug-resistant TB. As well, the group takes as its remit to mobilise the resources for these trials and to build the capacity of clinical trial sites.
Find out more about the activities of the DR-TB trials Working-Group
PLoS series on MDR TB clinical trials
